You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-negative breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Recruiting
  • Breast Cancer
  • +2 more
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 12, 2022

    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

    Terminated
    Has Results
    • Estrogen Receptor-negative Breast Cancer
    • +6 more
    • Baltimore, Maryland
      University of Maryland Baltimore
    Apr 29, 2022

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • ARV-471 (PF-07850327)
    • +2 more
    • Orange City, Florida
      Mid Florida Hematology and Oncology Center
    Jun 8, 2023

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Metastatic Breast Cancer Trial (Elacestrant)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2022

    Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

    Not yet recruiting
    • Estrogen-receptor-positive Breast Cancer
    • +3 more
    • elacestrant, palbociclib, abemaciclib, ribociclib
    • Chicago, Illinois
      Northwestern University
    Sep 25, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

    Completed
    • Advanced ER+, HER2-Negative Breast Cancer
    • Waltham, Massachusetts
      Radius Pharmaceuticals, Inc.
    Aug 16, 2022

    Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Carmel, Indiana
    • +2 more
    Apr 27, 2023

    HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

    Recruiting
    • HER2-positive Breast Cancer
    • +17 more
    • ALX148
    • Fam-Trastuzumab Deruxtecan-Nxki
    • Chicago, Illinois
    • +1 more
    May 19, 2023

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Breast Cancer Trial in New York (core needle biopsy, blood draw)

    Recruiting
    • Breast Cancer
    • core needle biopsy
    • blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Nov 9, 2023

    Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

    Active, not recruiting
    • Edema
    • +8 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 23, 2023

    Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • AND019 PO QD
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 19, 2022

    Breast Cancer Female Trial in Belgium (Palbociclib)

    Completed
    • Breast Cancer Female
    • Anderlecht, Belgium
    • +4 more
    Jun 23, 2022

    Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

    Recruiting
    • Breast Cancer
      • Shanghai, Shanghai, China
        Biyun Wang, MD
      Apr 5, 2023

      Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

      Active, not recruiting
      • Breast Cancer
      • Amcenestrant (SAR439859)
      • Chuo-Ku, Japan
      • +2 more
      Nov 16, 2022

      Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

      Not yet recruiting
      • Breast Cancer
      • (no location specified)
      May 22, 2023

      Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

      Completed
      Has Results
      • Estrogen Receptor Negative
      • +4 more
      • Duarte, California
      • +2 more
      Jun 6, 2022

      Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

      Recruiting
      • Breast Cancer
      • Denver, Colorado
      • +4 more
      Dec 12, 2022

      Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

      Active, not recruiting
      • Estrogen Receptor Positive
      • +3 more
      • Radiation Therapy
      • Therapeutic Conventional Surgery
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 14, 2022

      Recurrence Score on Adjuvant Treatment Decisions in Breast

      Recruiting
      • Breast Cancer Female
        • Tübingen, BW, Germany
          Department for Women's Health
        Nov 4, 2022